BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27803504)

  • 1. Incorporating a Pharmacist Into the Discharge Process: A Unit-Based Transitions of Care Pilot.
    Li H; Guffey W; Honeycutt L; Pasquale T; Rozario NL; Veverka A
    Hosp Pharm; 2016 Oct; 51(9):744-751. PubMed ID: 27803504
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing Readmission at an Academic Medical Center: Results of a Pharmacy-Facilitated Discharge Counseling and Medication Reconciliation Program.
    Zemaitis CT; Morris G; Cabie M; Abdelghany O; Lee L
    Hosp Pharm; 2016 Jun; 51(6):468-73. PubMed ID: 27354748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.
    Cunningham S; Kinsey JD
    Innov Pharm; 2020; 11(3):. PubMed ID: 34007627
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center.
    Nguyen PAA; Enwere E; Gautreaux S; Lin H; Tverdek F; Lu M; Cao H; Chase J; Roux R
    Am J Health Syst Pharm; 2018 Sep; 75(18):1386-1393. PubMed ID: 30065061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates.
    Still KL; Davis AK; Chilipko AA; Jenkosol A; Norwood DK
    Consult Pharm; 2013 Dec; 28(12):775-85. PubMed ID: 24322961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.
    Jones CD; Anthony A; Klein MD; Shakowski C; Smith HK; Go A; Perica K; Patel H; Pell J; Pierce R
    J Am Pharm Assoc (2003); 2018; 58(5):554-560. PubMed ID: 30017370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Pharmacist Medication Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI).
    Budiman T; Snodgrass K; Komatsu Chang A
    Ann Pharmacother; 2016 Feb; 50(2):118-24. PubMed ID: 26681443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an Integrated Pharmacy Transitions of Care Pilot Program in an Urban Hospital.
    Christy S; Sin B; Gim S
    J Pharm Pract; 2016 Oct; 29(5):490-4. PubMed ID: 25744762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Psychotropic Medications on Readmission Rates of Patients Receiving a Pharmacist Discharge Medication Reconciliation.
    Hefazi E; Boggie D; Huynh T; Lee KC
    J Pharm Pract; 2021 Oct; 34(5):741-745. PubMed ID: 32067567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist Transition-of-Care Services Improve Patient Satisfaction and Decrease Hospital Readmissions.
    March KL; Peters MJ; Finch CK; Roberts LA; McLean KM; Covert AM; Twilla JD
    J Pharm Pract; 2022 Feb; 35(1):86-93. PubMed ID: 32945206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study).
    Phatak A; Prusi R; Ward B; Hansen LO; Williams MV; Vetter E; Chapman N; Postelnick M
    J Hosp Med; 2016 Jan; 11(1):39-44. PubMed ID: 26434752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case-Control Study: The Impact of Unintentional Discrepancies and Pharmacist Discharge Prescription Review on 30-Day Hospital Readmission.
    Elbeddini A; Yang L; Aly A
    J Prim Care Community Health; 2020; 11():2150132720932012. PubMed ID: 32486942
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of pharmacy-driven transitional interventions in hospitalized patients with psychiatric disorders.
    Tillman F; Greenberg J; Liu I; Khalid S; McGuire N; Harris SC
    J Am Pharm Assoc (2003); 2020; 60(1):22-30. PubMed ID: 31859220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-Provided Medication Management in Interdisciplinary Transitions in a Community Hospital (PMIT).
    Rafferty A; Denslow S; Michalets EL
    Ann Pharmacother; 2016 Aug; 50(8):649-55. PubMed ID: 27273678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a Pilot Study for a Pharmacy Discharge Review in Neurosurgical Patients: A Quality-Safety Initiative.
    Greenwood JC; Gutierrez K; McDermott M
    Cureus; 2023 Mar; 15(3):e36067. PubMed ID: 37056529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a pharmacist-driven transitions of care clinic for a multisite integrated delivery network.
    Parodi M; Feeley B; Sanchez M
    Am J Health Syst Pharm; 2022 May; 79(11):844-851. PubMed ID: 35084448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of medication bedside delivery program on hospital readmission rates.
    Witcraft EJ; Norris AM; Fudzie SS; Vest MH; Johnson N; Rush J; Colmenares EW
    J Am Pharm Assoc (2003); 2021; 61(1):95-100.e1. PubMed ID: 33199165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients.
    Aniemeke E; Crowther B; Younts S; Hughes D; Franco-Martinez C
    Hosp Pharm; 2017 May; 52(5):348-352. PubMed ID: 28804150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.